Centogene provides precision medicine solutions through advanced diagnostics, multiomic testing, and bioinformatics platforms. The company serves physicians, patients, and pharmaceutical partners by offering genomic sequencing, biomarker testing, and data-driven insights to accelerate rare disease diagnosis, drug discovery, and personalized therapies.
Subscribe to see Centogene’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Centogene is a biotech company headquartered in Germany, founded in 2006. Xcout tracks 10 named people at Centogene, including Andy Chang (Chief Executive Officer, Asia Pacific). Xcout recorded 12 job postings from Centogene in the last 90 days.
4 more named people on record for Centogene, with roles, board committees and tenure — see the full roster →
Xcout recorded 12 job postings from Centogene in the last 90 days, from a hiring record Xcout has kept since May 2026.
The weekly hiring trend, the roles and locations behind it — see Centogene's hiring signals →
A few of Centogene's closest competitors — see the full list of competitors and alternatives →
Novigenix is an immuno-transcriptomics and TechBio company that provides precision oncology solutions for biopharmaceutical companies and researchers. It offers LITOseek, an AI-powered liquid biopsy platform that analyzes gene activity in immune cells to support biomarker discovery, therapy development, and patient response monitoring.
Diaceutics PLC, established in 2005 and headquartered in Belfast, UK, is a company dedicated to accelerating the commercialization of diagnostic solutions. It offers global pharmaceutical companies comprehensive data, advanced analytics, and implementation support. Central to its operations is the DXRX platform. This platform features DXRX data solutions, providing access to extensive diagnostic testing data pipelines from a broad network of laboratories, including real-time DXRX signal alerts, lab and physician mapping, and a testing dashboard. The DXRX platform also hosts a marketplace where laboratories, pharmaceutical firms, and diagnostic companies can connect to collaborate on precision medicine diagnostics. Diaceutics further provides DXRX Patient Journey, a tool for pharmaceutical clients to conduct detailed longitudinal analyses of individual patient biomarker testing paths, helping identify opportunities for earlier intervention and treatment. DXRX Lab Benchmarking allows laboratories to sharpen their competitive edge by comparing their key criteria against industry counterparts, encompassing metrics such as disease focus, testing methodologies, market share, turnaround times, and their standing as leaders in specific diagnostic fields. The DXRX Test Reimbursement service assists pharma clients in funding novel companion diagnostics, thereby shortening the time required for their widespread adoption. Furthermore, DXRX Test Signal delivers immediate notifications of testing events, empowering pharmaceutical clients to swiftly identify therapeutically actionable patients. Beyond the platform, Diaceutics furnishes services for diagnostic landscape analysis, strategic planning, implementation, and ongoing tracking, alongside expert consulting tailored to precision medicine diagnostics. Its extensive service portfolio also covers test standardization, quality evaluations, optimization of test reports, technical laboratory support, assistance with test access and reimbursement, laboratory training, and various educational resources.
IntegraGen develops genomic tests, molecular diagnostic products, and bioinformatics software for researchers, clinicians, and biopharma companies. The company specializes in oncology and genetic diseases, offering next-generation sequencing services, data analysis tools, and biomarker identification to support clinical research and diagnostics.
CellCarta operates as a global contract research organization (CRO) providing specialized laboratory testing and biomarker services to support drug development and precision medicine. The company offers a wide range of services including immunology, proteomics, genomics, histopathology, and companion diagnostic development for pharmaceutical and biotechnology clients.
Source BioScience is a UK-based laboratory services company providing genomics, DNA sequencing, molecular diagnostics, and pathology-related testing. It serves pharmaceutical and biotechnology companies, healthcare organizations, research institutions, and other life-science customers.
Access Genetics LLC operates a national reference laboratory that provides personalized diagnostics and molecular DNA testing services, including salivary diagnostics through its OralDNA Labs division. The company serves healthcare clients and patients by offering comprehensive diagnostic test options and clinical lab services.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.